Dose proportionality : Phase 1 data suggest approximately dose-proportional pharmacokinetics across the tested dose ranges, with predictable accumulation upon repeated weekly dosing
BrandShield CEO Yoav Keren showed CNBC various sites that the company flagged and that ultimately got shut down, including a Facebook account and a TikTok account that impersonated GLP-1 makers and sold versions of the drug
Emerging 2025 research suggests semaglutide (the drug in Ozempic and Wegovy) is associated with lower RA disease activity, less pain, and improved joint outcomes especially in patients who also carry excess weight
Liraglutide effect on atherosclerosis was studied on both human atherosclerotic plaque cultures and human peripheral blood macrophages as well as apoE / mice on a high-fat, high-cholesterol diet
Q2: Who is a good candidate for GLP-1 peptide therapy in Miami
The FDA provided enforcement discretion periods: 503A pharmacies (like Belmar's patient-specific facilities) could continue compounding semaglutide until April 22, 2025, while 503B outsourcing facilities had until May 22, 2025